MedPlus Health Services (MEDPLUS.BO) Earnings Analysis
MedPlus Health Services (MEDPLUS.BO) next reports earnings on 2026-11-05. Last quarter (2026-07-21) it beat with EPS 2.8 INR vs 1.95 INR est (+43.6%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 40.73.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MEDPLUS.BO next report earnings?
| Next earnings date | 2026-11-05 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
MEDPLUS.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-21 | 2.8 INR | 1.95 INR | +43.6% | Beat |
| 2026-05-20 | 5.3 INR | 5.2 INR | +1.9% | Beat |
| 2026-01-30 | 5.35 INR | 4.8 INR | +11.5% | Beat |
| 2025-09-29 | 4.62 INR | 4.15 INR | +11.3% | Beat |
| 2025-07-31 | 3.53 INR | 2.85 INR | +23.9% | Beat |
| 2025-05-27 | 4.29 INR | 3.8 INR | +12.9% | Beat |
| 2025-01-31 | 3.82 INR | 2.7 INR | +41.5% | Beat |
| 2024-08-02 | 1.2 INR | 0.6 INR | +100% | Beat |
Beat rate: 8/8 (100%) over reported quarters with consensus data.
MEDPLUS.BO valuation and analyst view
| Trailing P/E | 40.73 |
|---|---|
| Trailing EPS | 17.527 INR |
| Price / book | 4.35 |
| Dividend yield | 0.00% |
| Market cap | 83.09B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is MedPlus Health Services (MEDPLUS.BO)'s next earnings date?
MedPlus Health Services is next scheduled to report on 2026-11-05.
Did MEDPLUS.BO beat earnings last quarter?
In its 2026-07-21 report, MEDPLUS.BO posted EPS of 2.8 INR versus a 1.95 INR estimate — a beat of 43.6%.
What is MEDPLUS.BO's earnings track record?
Over the last 8 reported quarters with consensus data, MEDPLUS.BO beat estimates 8 times (100%).
What is MEDPLUS.BO's current P/E ratio and EPS?
MEDPLUS.BO trades at a trailing P/E of 40.73 on trailing EPS of 17.527215059712425 INR.
What do analysts rate MEDPLUS.BO?
MEDPLUS.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.